Biotronik SE & Co. KG - Strategic SWOT Analysis Review
GlobalData
February 6, 2012 33 Pages - SKU: GBDT6797574
|
|
Biotronik SE & Co. KG - Strategic SWOT Analysis Review
Summary
Biotronik SE & Co. KG (Biotronik) is one of the leading biomedical technology company that offers devices for cardiac rhythm management and vascular intervention. The company operates with focus on two business areas, namely, Vascular Intervention and Electrotherapy. Its Electrotherapy offering include diagnostic tools and options for treating arrhythmias; where as its Vascular Intervention solutions provide services for stenosis and occlusion of arterial vessels. Through a well established network across 100 countries, Biotronik markets its products in Europe, North America, Latin America, Asia, Oceania and Africa.
Biotronik SE & Co. KG Key Recent Developments
Jan 13, 2012 BIOTRONIK Opens New Asia Pacific Headquarters In Singapore
Nov 07, 2011 BIOTRONIK Presents New Economic Model: Remote Monitoring Reduces Hospital Workload And Healthcare Costs For Patients With Cardiac Implantable Electrical Devices
Oct 18, 2011 BIOTRONIK Launches First 20mm-200mm Stents On 4 F Platform For Treatment Of SFA And BTK Disease
Sep 01, 2011 PREVENT Study Indicates Potential For Reduced Risk Of Adverse Clinical Outcomes With Enhanced BIOTRONIK Pacemaker Algorithm
Aug 25, 2011 BIOTRONIK Announces Compelling Program Of Clinically And Scientifically Significant Presentations At ESC Congress 2011
GlobalData’s Biotronik SE & Co. KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - GlobalData’s summarization of the company’s business strategy.
- SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities - A list of key manufacturing facilities of the company.
Note: Some sections may be missing if data is unavailable for the company.
Reasons to Buy- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
|
Section 1 - About the Company - Biotronik SE & Co. KG - Key Facts
- Biotronik SE & Co. KG - Key Employees
- Biotronik SE & Co. KG - Major Products and Services
- Biotronik SE & Co. KG - Medical Equipment Pipeline Products Data
- Biotronik SE & Co. KG Pipeline Products by Equipment Type
- Biotronik SE & Co. KG Pipeline Products by Development Stage
- Biotronik SE & Co. KG - History
- Biotronik SE & Co. KG - Company Statement
- Biotronik SE & Co. KG - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Section 2 - Company Analysis
- Biotronik SE & Co. KG - Business Description
- Biotronik SE & Co. KG - SWOT Analysis
- SWOT Analysis - Overview
- Biotronik SE & Co. KG - Strengths
- Strength - Vertically Integrated Operations
- Strength - Product Innovation
- Strength - Well Established Player
- Biotronik SE & Co. KG - Weaknesses
- Weakness - Product Recalls
- Biotronik SE & Co. KG - Opportunities
- Opportunity - New Product Launches and Approvals
- Opportunity - Growing Aged Population
- Opportunity - Global Cardiovascular Devices Market
- Biotronik SE & Co. KG - Threats
- Threat - Stringent Government Regulations
- Threat - Competitive Landscape
- Threat - Risk of Product Obsolesce
- Biotronik SE & Co. KG - Key Competitors
- Section 3 - Company’s Lifesciences Financial Deals and Alliances
- Biotronik SE & Co. KG, Medical Equipment, Deals By Year, 2006 to YTD 2012
- Biotronik SE & Co. KG, Medical Equipment, Deals By Type, 2006 to YTD 2012
- Biotronik SE & Co. KG, Recent Deals Summary
- Section 4 - Company’s Recent Developments
- Biotronik SE & Co. KG, Recent Developments
- Jan 13, 2012: BIOTRONIK Opens New Asia Pacific Headquarters In Singapore
- Nov 07, 2011: BIOTRONIK Presents New Economic Model: Remote Monitoring Reduces Hospital Workload And Healthcare Costs For Patients With Cardiac Implantable Electrical Devices
- Oct 18, 2011: BIOTRONIK Launches First 20mm-200mm Stents On 4 F Platform For Treatment Of SFA And BTK Disease
- Sep 01, 2011: PREVENT Study Indicates Potential For Reduced Risk Of Adverse Clinical Outcomes With Enhanced BIOTRONIK Pacemaker Algorithm
- Aug 25, 2011: BIOTRONIK Announces Compelling Program Of Clinically And Scientifically Significant Presentations At ESC Congress 2011
- Jul 22, 2011: BIOTRONIK Enters US With First Peripheral Stent Implant In BIOFLEX-I IDE Clinical Trial
- Jul 13, 2011: BIOTRONIK Announces First Patients Treated In BIOFLOW-II Clinical Study Comparing ORSIRO Hybrid Drug-Eluting Stent To Abbott's XIENCE PRIME
- Jun 28, 2011: BIOTRONIK Announces Completion Of Enrollment In 4EVER Clinical Study Including Long Lesions In Peripheral Vascular Disease
- Apr 27, 2011: BIOTRONIK Receives FDA Approval For Expansion Of Evia Pacemaker Portfolio
- Apr 22, 2011: Novation Adds BIOTRONIK To Its Cardiac Rhythm Management Product Portfolio
- Section 5 - Appendix
- Methodology
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- Biotronik SE & Co. KG, Key Facts
- Biotronik SE & Co. KG, Key Employees
- Biotronik SE & Co. KG, Major Products and Services
- Biotronik SE & Co. KG Number of Pipeline Products by Equipment Type
- Biotronik SE & Co. KG Pipeline Products by Equipment Type
- Biotronik SE & Co. KG Number of Pipeline Products by Development Stage
- Biotronik SE & Co. KG Pipeline Products by Development Stage
- Biotronik SE & Co. KG, History
- Biotronik SE & Co. KG, Subsidiaries
- Biotronik SE & Co. KG, Key Competitors
- Biotronik SE & Co. KG, Medical Equipment, Deals By Year, 2006 to YTD 2012
- Biotronik SE & Co. KG, Medical Equipment, Deals By Type, 2006 to YTD 2012
- Biotronik SE & Co. KG, Recent Deals Summary
- List of Figures
- Biotronik SE & Co. KG Pipeline Products by Equipment Type
- Biotronik SE & Co. KG Pipeline Products by Development Stage
- Biotronik SE & Co. KG, Medical Equipment, Deals By Year, 2006 to YTD 2012
- Biotronik SE & Co. KG, Medical Equipment, Deals by Type, 2006 to YTD 2012
Share this report
Other tasks Related Markets Diagnostics Company Reports Free Alert Me service Receive bi-weekly email alerts on new market research Sign Up Today!
|
